Hui-Zhao Hong

Papers

Total Citations

H-Index

About

Dr. Hui-Zhao Hong is a thoracic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for non-small cell lung cancer (NSCLC), particularly in the context of neoadjuvant therapy. Dr. Hong’s most cited study, a 2025 propensity score–matched analysis, demonstrates the significant advantages of robotic-assisted thoracic surgery (RATS) over traditional approaches for patients who have undergone preoperative chemotherapy or immunotherapy. This work provides critical evidence that RATS reduces postoperative complications and hospital stays, even in this high-risk population, thereby improving recovery and quality of life. With 5 citations already, this paper is gaining traction as a key reference in the field. Dr. Hong’s research bridges the gap between oncologic treatment and surgical innovation, offering a safer, more precise option for complex lung cancer cases. Their contributions are shaping clinical guidelines and inspiring further investigation into robotic platforms. For students and researchers, Dr. Hong exemplifies how rigorous comparative studies can directly translate into better patient outcomes, making their work essential reading for anyone interested in the future of thoracic oncology and surgical robotics.